About usSign in
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • USA: Maryland
  • California
  • Texas
  • North Carolina
  • Massachusetts; Germany: Munich.
Investment stages
  • Seed
  • Series A
Industries
  • Health Tech
  • Bio Technology
About
Arcus Ventures (AV) consists of a team of professionals with experience in clinical and academic medicine, drug development, hospital management, healthcare industry consulting, and private equity. AV is dedicated to investing in oncologyfocused companies with innovative biopharmaceuticals and/or new drug delivery platforms in development, device companies with products that have premarketing approval, and service companies with positive revenue.
Min check size
$1M
Max check size
$3M
Fund size
NPS

Investment Thesis

Arcus Ventures is dedicated to investing in oncologyfocused companies with innovative biopharmaceuticals, new drug delivery platforms in development, device companies with premarketing approval, and service companies with positive revenue.
Lead investor
Co Invest
Number of exits
Preferred contact method

Arcus Ventures Contacts Information

Team

James B. Dougherty

MD

MBA General Partner

Steven L. Soignet

MD General Partner

Chad C. Hellmann

MBA Chief Financial Officer

Portfolio

MacroGenics

Tracon

T2 Biosystems

Clear Vascular

Inc.

Epic Sciences

Cleave Therapeutics

Palyon Medical

MI Bioresearch

Vascular Pathways

Oncoscope

Exosome Diagnostics

XTuit Pharmaceuticals

Genta

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp